Utah and Louisiana have joined the growing list of states that have taken steps to reduce deaths from opioid overdose.

The American Medical Association recently followed Dr. Phillip Seo for its "Shadow Me" series, which is meant to offer insight into what a particular specialist does.

Mental health advocates and professionals across the country are awaiting the appointment of an assistant secretary to lead the agency charged with tackling mental illness, a new position created by recently enacted legislation.

Vifor Pharma will pay $20 million to ChemoCentryx for the rights to sell a renal disease drug in all markets outside the United States and China, the company announced recently.

The Centers for Medicare and Medicaid Services recently proposed rule-changing regulations for the Affordable Care Act Marketplace insurance plans that would impact cancer patients by changing special enrollment periods and requirements that are included in open insurance plans.

PhRMA's recent national health care dialogue series, held on Feb. 21, was the first ever by the company. 

A study from the American Heart Association reveals that unnecessary healthcare procedures and costs may be linked to errorneous ICD shocks.

The American Hospital Association recently noted that the Centers for Disease Control and Prevention, this flu season's vaccine has been 48 percent effective at the prevention of flu-related outpatient visits in the category of acute respiratory illness.

The American Diabetes Association has issued guidelines on diabetes prevention, assessment and treatment in the article, "Diabetic Retinopathy: A Position Statement by the American Diabetes Association," which will be published in the March 2017 issue of Diabetes Care.

The 2017 Myeloma Action Month campaign -- sponsored by the International Myeloma Foundation -- began Wednesday to educate health care workers, legislators and patients on the disease.

Ten physicians will be recognized for their efforts and contributions in stroke research advancement and treatment.

The Pharmaceutical Research and Manufacturers of American recently hosted the “Through the Microscope: Examining Modern Medicine” national health care discussion series sponsored as part of the new GOBOLDLY campaign.

Shire recently launched "Rare Count" in honor of Rare Disease Day and the 350 million people worldwide living with rare diseases, which equates to nearly one in 20 global citizens.

Cancer patients with a nurse navigator rated their care higher and reported fewer problems than patients without one, according to a study recently published in the Journal of Clinical Oncology.  

A new study suggests that the same estrogen therapy used to treat osteoporosis can lead to healthier teeth and gums.

Although tissue plasminogen activator (tPA)  treatment for strokes is increasing over time, minorities, women and residents of 11 Southeastern states that make up the “Stroke Belt” are left behind when it comes to receiving tPA.

Patients hospitalized or treated in the emergency room for depression, anxiety, post-traumatic stress disorder or other psychiatric disorders may have an increased risk for stroke, particularly in the 15 days following their psychiatric diagnosis.

A Phase 1 clinical trial to test the safety and tolerability of an investigational vaccine against respiratory syncytial virus has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.

A National Institutes of Health-supported report found that in older men with low testosterone, one year of testosterone treatment improved bone density and corrected anemia of both known and unknown causes, but also increased the volume of coronary artery plaque.

Real Endpoints recently conducted research that found significant variability in treatment preferences among multiple sclerosis patients, as well as a difference in how patients define value in MS therapies compared to payers and physicians.